Publications

5891 Results

A randomized phase III non-inferiority trial of irinotecan (CPT-11) versus oxaliplatin (OXAL)/5-fluorouracil (5-FU)/leucovorin (CF) in patients with advanced colorectal carcinoma previously treated with 5-FU, N9841 [PMC2698019; PMID19380443]

Authors
GP Kim;DJ Sargent;MR Mahoney;KM Rowland;PA Philip;E Mitchell;AP Mathews;TR Fitch;RM Goldberg;SR Alberts;HC Pitot
Journal / Conference
Journal of Clinical Oncology 27(17):2848-2854
Year
2009
Research Committee(s)
Gastrointestinal
Study Number(s)
N9841

Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the North Central Cancer Treatment Group Phase 3 trial (N9831) [PMC2690390; PMID19349549]

Authors
MY Halyard;TM Pisansky;AC Dueck;V Suman;L Pierce;L Solin;L Marks;N Davidson;S Martino;P Kaufman;L Kutteh;SR Dakhil;EA Perez
Journal / Conference
Journal of Clinical Oncology 27(16):2638-2644
Year
2009
Research Committee(s)
Breast
Study Number(s)
N9831

Quality of pathologic response and surgery correlate with survival for completely resected bladder cancer following neoadjuvant MVAC

Authors
G Sonpavde;B Goldman;VO Speights;SP Lerner;DP Wood;NJ Vogelzang;DL Trump;RB Natale;HB Grossman;ED Crawford
Journal / Conference
ASCO 2009 GU Cancers Symposium, abst. #249
Year
2009
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). PMID:19066370; PMC3682779

Authors
SM Lippman;EA Klein;P Goodman;MS Lucia;IM Thompson;LG Ford;HL Parnes;LM Minasian;JM Gaziano;JA Hartline;JK Parsons;JD Bearden;ED Crawford;GE Goodman;J Claudio;E Winquist;ED Cook;DD Karp;PJ Walther;MM Lieber;AR Kristal;A Darke;K Arnold;PA Ganz;RM Santella;D Albanes;PR Taylor;JL Probstfield;TJ Jagpal;JJ Crowley;FL Meyskens;LH Baker;CA Coltman
Journal / Conference
Journal of the American Medical Association 301(1)39-51
Year
2009
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Variability in surgical quality in a randomized clinical trial of adjuvant chemotherapy following radical cystectomy and pelvic lymphadenectomy

Authors
SP Lerner;JP Stein;WP Stadler;S Groshen;Ellenie Tuazon;DG Skinner;D Raghavan;D Esrig;G Steinberg;L Klotz;C Hall;R Cote
Journal / Conference
American Urological Association 2009 Annual Meeting, abstract #1747, poster presentation
Year
2009
Research Committee(s)
Genitourinary
Study Number(s)
4B951

Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124 [PMID19349543; PMC2684855]

Authors
PN Lara;RB Natale;JJ Crowley;HJ Lenz;M Redman;JE Carleton;J Jett;CJ Langer;JP Kuebler;SR Dakhil;K Chansky;DR Gandara
Journal / Conference
Journal of Clinical Oncology 27(15):2530-2535
Year
2009
Research Committee(s)
Lung
Study Number(s)
S0124

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial [PMID 19167731]

Authors
IM Thompson;CM Tangen;JC Paradelo;MS Lucia;GJ Miller;DA Troyer;EM Messing;JD Forman;JL Chin;GP Swanson;ED Canby-Hagino;ED Crawford
Journal / Conference
Journal of Urology 181(3):956-962
Year
2009
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8794

Quality of pathologic response and surgery correlate with survival for completely resected bladder cancer following neoadjuvant chemotherapy. 2009 [PMID19517476; PMC3079554]

Authors
G Sonpavde;B Goldman;VO Speights;SP Lerner;DP Wood;SP Lerner;DL Trump;RB Natale;HB Grossman;ED Crawford
Journal / Conference
Cancer 115(18):4104-4109
Year
2009
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)

Cisplatin (Cis) + irinotecan (CPT11) vs. Cis + etoposide (VP16) in extensive stage small cell lung cancer (E-SCLC): final comparative outcomes analysis of JCOG 9511 and SWOG 0124

Authors
PN Lara;K Chansky;T Shibata;H Fukuda;T Tamura;N Saijo;HJ Lenz;RB Natale;JJ Crowley;DR Gandara
Journal / Conference
Journal of Clinical Oncology 27:15s, abst. #8027
Year
2009
Research Committee(s)
Lung
Study Number(s)
S0124

A phase II trial of imatinib mesylate in Merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331)

Authors
WE Samlowski;J Moon;RJ Tuthill;MC Heinrich;NS Balzer-Haas;SA Merl;RC DeConti;JA Thompson;LE Flaherty;VK Sondak
Journal / Conference
Journal of Clinical Oncology 27:15s, abst.#9056
Year
2009
Research Committee(s)
Melanoma
Study Number(s)
S0331